+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Liver Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Liver Cancer Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
MSI-H and dMMR Market Report 2025 - Product Thumbnail Image

MSI-H and dMMR Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Gastrointestinal Cancer Global Market Report 2025 - Product Thumbnail Image

Gastrointestinal Cancer Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Immuno-Oncology Drugs Market Report 2025 - Product Thumbnail Image

Immuno-Oncology Drugs Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Bone Cancer Treatment Market Report 2025 - Product Thumbnail Image

Bone Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Esophageal Cancer Market Report 2025 - Product Thumbnail Image

Esophageal Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Liver Cancer Drug Global Market Report 2025 - Product Thumbnail Image

Liver Cancer Drug Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto-oncogene Protein C-bcl-2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Compounding Chemotherapy - Global Strategic Business Report - Product Thumbnail Image

Compounding Chemotherapy - Global Strategic Business Report

  • Report
  • September 2025
  • 470 Pages
  • Global
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • September 2025
  • 396 Pages
  • Global
From
Laryngeal Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Laryngeal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 273 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • September 2025
  • 582 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more